• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
TechEngage

TechEngage

Technology news and opinions

  • Tech News
  • Reviews
  • How-to
  • Science
    • Energy
    • Environment
    • Health
    • Space
  • Apps
  • More
    • Opinion
    • Noteworthy
    • Roundups
    • Culture
    • Blockchain
      • Cryptocurrency
    • Events
    • Deals
    • Startups
      • Startup Submissions
  • Videos
  • Login
Health, Health Care

UK has approved Pfizer-BioNTech Coronavirus vaccine for distribution

Avatar for Amnah Fawad Amnah Fawad December 2, 2020

Coronavirus vaccine illustration
Image: Freepik

Incredible news from the UK folks; the Pfizer-BioNTech collab COVID-19 vaccine has sought the Medicines and Healthcare products Regulatory Agency (MHRA) approval and will be available for the public soon. Just as we are hearing about many ambitious companies like Moderna applying for emergency authorization of their COVID-19 vaccine, an actual approval has breathed a new life among many.

The vaccine will be available in the UK from next week. It is especially great news for the UK as the country is ranked at 7th (as of today) for having the most cases of the coronavirus by the World Health Organization.

In a time when the second wave of the life-threatening virus is surging rapidly, the news has given a ray of hope to the majority of the healthcare workers and researchers.

The government statement, Reuters reported:

“The government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s COVID-19 vaccine for use. The vaccine will be made available across the UK from next week,”

The two companies came together to collaborate their efforts for the development of a sound vaccine to counter coronavirus in April this year. One of the immediate aims of this collaboration, right after the development of the vaccine, was to scale up its production and make it available for use globally.

Albert Bourla, the CEO of Pfizer, stated, The Guardian quotes:

“This authorisation is a goal we have been working toward since we first declared that science will win, and we applaud the MHRA for their ability to conduct a careful assessment and take timely action to help protect the people of the UK,”

“As we anticipate further authorisations and approvals, we are focused on moving with the same level of urgency to safely supply a high-quality vaccine around the world.”

While many of us are contemplating as to who would have access to the vaccine first, the government is all set to decide which fraction of the population will have access to the vaccine in its initial stages. The distribution of the vaccine will be on a priority basis. According to this, the priority will be given to the healthcare workers and the most vulnerable of the people; the elderly and immune-compromised patients.

The hospitals are prepared to launch the vaccine distribution program as per the tweet by the UK health secretary, Matt Hancock:

Help is on its way.

The MHRA has formally authorised the Pfizer/BioNTech vaccine for Covid-19.

The NHS stands ready to start vaccinating early next week.

The UK is the first country in the world to have a clinically approved vaccine for supply.

— Matt Hancock (@MattHancock) December 2, 2020

The armed forces, along with the NHS, have already made necessary preparations for the proper distribution of the vaccine.

On the distribution of the vaccine, the NHS chief executive, Sir Simon Stevens, said:

“The NHS has a proven track record of delivering large scale vaccinations from the winter flu jab to BCG and, once the final hurdles are cleared and the vaccine arrives in England’s hospitals, health service staff will begin offering people this ground-breaking jab in a programme that will expand to cover the whole country in the coming months.”

Oksana Pyzik, a teaching fellow at the UCL School of Pharmacy, told Al Jazeera,

“We know that Pfizer can have only 1.3 billion doses by the end of next year. That is definitely not going to vaccinate the world, but we are going to take this first crucial step which is exciting.”

Since the vaccine ought to be stored at extremely cold temperatures, its distribution can be a crucial task outside hospitals.

Related Tags: BioNTech Coronavirus Covid19 Pfizer Vaccines

Related Stories

  • Technology and healthcare: the duo revolutionizing our lives

    Technology and healthcare: the duo revolutionizing our lives

  • Is the NIH trying to discourage collaboration between U.S. and Chinese researchers?

    Is the NIH trying to discourage collaboration between U.S. and Chinese researchers?

  • Breast Cancer Prevention; what can be done?

    Breast Cancer Prevention; what can be done?

Avatar for Amnah Fawad

Amnah Fawad

Editor

Content writer by profession, but a scientist at heart who secretly believes the conspiracy theories about AI taking over the world. Tech-savvy, sucker of sci-fi thrillers who loves to travel.

Reader Interactions

Join The Discussion: Cancel reply

Please read our comment policy before submitting your comment. Your email address will not be used or publish anywhere. You will only receive comment notifications if you opt to subscribe below.

Primary Sidebar

Become a contributor

We are accepting contributor applications. All applications will be decided in 3 days after applying. To learn more click here.
TechEngage-Apple-News
TechEngage-Google-News

Recent Stories

  • Best office desks on Amazon for comfort in 2021
  • Top-rated best dishwashers on Amazon for 2021
  • Samsung S21 series is here and we’ve got everything you need to know
  • Best laptop cooling pads for 2021 on Amazon
  • Best standing desks on Amazon for 2021
top background apps

Best Wallpaper Apps Android 2021

Top 5 wireless headphones

Top 5 Wireless Headphones for your Work-Out

An iPhone 6s mockup with live wallpaper

How to use any video or GIF as iPhone live wallpaper

Public user data stats

How to start collecting public data online

Footer

About Us

  • Advertise
  • Send us a tip
  • Startup Submission Questionnaire
  • Community Guidelines
  • Corrections Policy & Practice
  • Contact us

Discover

  • About
  • Newsroom
  • Advertise
  • Brand Kit
  • Partners
  • Staff
  • Our Ethics
  • Publication Principles
  • Contact us

Legal Pages

  • Reviews Guarantee
  • Community Guidelines
  • Cookies Policy
  • Comments Policy
  • Our Ethics
  • Disclaimer
  • GDPR Compliance
  • Privacy Policy
  • Terms and Conditions

Download our apps

TechEngage-app-google-play-store

Copyright © 2021 · All Rights Reserved · TechEngage® is a Project of TechAbout LLC.
TechEngage® is a registered trademark in United Kingdom under Trademark Number UK00003417167 and is ISSN protected under the ISSN 2690-3776 and OCLC Number 1139335774.